# Treatment of Oral Warts in HIV+ Patients

> **NCT00454181** · PHASE2 · COMPLETED · sponsor: **Ainos, Inc. (f/k/a Amarillo Biosciences Inc.** · enrollment: 59 (actual)

## Conditions studied

- Papillomatosis
- HIV Infections

## Interventions

- **DRUG:** Interferon-alpha
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00454181
- **Lead sponsor:** Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2009-09
- **Final completion:** 2009-10
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2011-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00454181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00454181, "Treatment of Oral Warts in HIV+ Patients". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00454181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*